Chelsea Therapeutics to cut jobs, CEO resigns

July 10 (Reuters) - Chelsea Therapeutics International Ltd said it plans to "significantly reduce" its workforce and explore strategic options, barely a week after the U.S. health regulator asked for an additional trial to approve its hypotension drug Northera.